Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
4 Results for "
methylated negative control compound
" in MedChemExpress (MCE) Product Catalog:
Products (4)
4 Results for "methylated negative control compound" in MCE Product Catalog:
Cat. No.: HY-125655
CAS No.: 1872382-50-7
Target:
Research Areas:
UNC-4219 TFA is a negative control for the CBX7-H3 antagonist UNC3866 (HY-100832) and does not interact with CBX7 at high concentrations .
Cat. No.: HY-159015
SIAIS630120-NC is a negative control PROTAC compound synthesized using a methylated CRBN ligand, which serves as a control for SIAIS630120. SIAIS630120-NC lacks NAMPT degradation activity. SIAIS630120-NC exerts no cytotoxic effect on hematological tumor cells .
Cat. No.: HY-176821
CAS No.: 2650530-01-9
Target:
Research Areas:
PFI-6N is a negative control compound of PFI-6 (HY-155412). PFI-6N is completely inactive against YEATS domain (MLLT1/3 and YEATS2/4) by methylating the amide of PFI-6 .
Cat. No.: HY-185557
CAS No.: 3063448-59-6
Target:
Research Areas:
LLC0424N is a negative control compound designed by methylating the thalidomide moiety of LLC0424 (HY-161574). LLC0424N shows does not induce NSD2 degradation and inhibit growth of acute lymphoblastic leukemia cells with NSD2 mutation. LLC0424N can be used for the research of acute lymphoblastic leukemia .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
